News
Important Only
Zenas Biopharma Announces Late-Breaking Platform Presentation Of Results From Phase 2 Moonstone Trial Of Obexelimab In Relapsing Multiple Sclerosis At Actrims Forum 2026
Feb 9 (Reuters) - Zenas Biopharma Inc ZBIO.O:ZENAS BIOPHARMA ANNOUNCES LATE-BREAKING PLATFORM PRESENTATION OF RESULTS FROM PHASE 2 MOONSTONE TRIAL OF OBEXELIMAB IN RELAPSING MULTIPLE SCLEROSIS AT ACTRIMS FORUM 2026Reuters
16 hours ago
Advantage Solutions Inc Estimate Revenues For Year Ended Dec 31, 2025 Will Be Between $3,500 Million And $3,550 Million
Feb 9 (Reuters) - Advantage Solutions Inc ADV.O:: ESTIMATE REVENUES FOR YEAR ENDED DEC 31, 2025 WILL BE BETWEEN $3,500 MILLION AND $3,550 MILLIONADVANTAGE SOLUTIONS : ESTIMATE OPERATING LOSS FROM CONTINUING OPERATIONS FOR YEAR ENDED DEC 31, 2025 WILL BE BETWEEN $130 MILLION AND $120 MILLIONFY2025 RE...Reuters
16 hours ago
Powerfleet's Q3 sales beat expectations on higher recurring revenue growth
OverviewAIoT platform's Q3 revenue rose 7% yr/yr, beating analyst expectationsAdjusted EBITDA for Q3 slightly beat analyst estimatesCompany secured major South Africa public sector contract for AI video servicesOutlookPowerfleet tightens full-year revenue guidance to $440 mln-$445 mlnCompany exp...Reuters
16 hours ago
Valore Approves Phase 2 Of Metallurgical Testwork For Pedra Branca Pge Project In Brazil Program Underway In Partnership With The University Of Cape Town Department Of Chemical Engineering
Feb 9 (Reuters) - ValOre Metals Corp VO.V:VALORE APPROVES PHASE 2 OF METALLURGICAL TESTWORK FOR PEDRA BRANCA PGE PROJECT IN BRAZIL: PROGRAM UNDERWAY IN PARTNERSHIP WITH THE UNIVERSITY OF CAPE TOWN DEPARTMENT OF CHEMICAL ENGINEERINGReuters
16 hours ago
Hain Celestial Q2 revenue slightly beats estimates
OverviewHealth and wellness firm's fiscal Q2 revenue slightly beat analyst expectationsAdjusted EPS for fiscal Q2 missed analyst expectationsCompany divested North American snack business to improve financial flexibilityOutlookCompany expects sequential improvement in the back half of the yearCo...Reuters
16 hours ago
Contract research firm Inotiv's Q1 operating loss widens
OverviewContract research firm's fiscal Q1 2026 revenue rose 0.8% yr/yrAdjusted EBITDA for fiscal Q1 2026 missed analyst expectationsCompany exited two leased facilities as part of site optimization planOutlookCompany did not provide specific guidance for future quarters or full yearResult Drive...Reuters
16 hours ago
SparingVision Successfully Completes Prodygy Trial Patient Dosing With Spvn06, Its Novel Neuroprotective Gene Therapy
Feb 9 (Reuters) - SPARINGVISION SUCCESSFULLY COMPLETES PRODYGY TRIAL PATIENT DOSING WITH SPVN06, ITS NOVEL NEUROPROTECTIVE GENE THERAPYSPARINGVISION: INITIAL DATA READOUT FOR NOVEL GENE-AGNOSTIC THERAPY EXPECTED IN 2027SPARINGVISION: ALL PATIENTS DOSED WITH SPVN06 IN PHASE I/II TRIAL CONTINUE TO DEM...Reuters
16 hours ago
Select Water Solutions And Libertystream Infrastructure Partners Announce Definitive Agreement To Build Out Commercial Lithium Carbonate Production Units In Texas First 1,000-Tonne Facility Slated For Commissioning By December 2026
Feb 9 (Reuters) - LibertyStream Infrastructure Partners Inc LIB.V:SELECT WATER SOLUTIONS AND LIBERTYSTREAM INFRASTRUCTURE PARTNERS ANNOUNCE DEFINITIVE AGREEMENT TO BUILD OUT COMMERCIAL LITHIUM CARBONATE PRODUCTION UNITS IN TEXAS; FIRST 1,000-TONNE FACILITY SLATED FOR COMMISSIONING BY DECEMBER 2026SE...Reuters
16 hours ago
Osisko Development Awards Project And Construction Management Services Contract For The Development Of The Cariboo Gold Project
Feb 9 (Reuters) - Osisko Development Corp ODV.V:OSISKO DEVELOPMENT AWARDS PROJECT AND CONSTRUCTION MANAGEMENT SERVICES CONTRACT FOR THE DEVELOPMENT OF THE CARIBOO GOLD PROJECTReuters
16 hours ago
Monday.Com Announces Fourth Quarter And Fiscal Year 2025 Results
Feb 9 (Reuters) - monday.com Ltd 6B6.F:MONDAY.COM ANNOUNCES FOURTH QUARTER AND FISCAL YEAR 2025 RESULTSMONDAY.COM LTD - OUTLOOK FY 2026 REVENUE $1,452-$1,462 MILLIONMONDAY.COM LTD - OUTLOOK Q1 2026 REVENUE $338-$340 MILLIONMONDAY.COM LTD - Q4 REVENUE OF $333.9 MILLION, UP 25% YOYReuters
16 hours ago
Inspira Secures Vendor Approval From $12 Billion Revenue Hmo (World’S 2Nd Largest), Enabling Immediate ART100 Deployment
Feb 9 (Reuters) - Inspira Technologies Oxy BHN Ltd IINN.O:INSPIRA SECURES VENDOR APPROVAL FROM $12 BILLION REVENUE HMO (WORLD’S 2ND LARGEST), ENABLING IMMEDIATE ART100 DEPLOYMENTINSPIRA TECHNOLOGIES OXY BHN LTD - ART100 APPROVED FOR IMMEDIATE USE IN CLALIT'S MEDICAL ECOSYSTEMReuters
16 hours ago
Morning News Call - U.S., February 9
To access a PDF version of this newsletter, please click hereYou can read Morning News Call -- US via TOPNEWS U.S. Companies page.If you would like to receive this newsletter through your email, please register at:https://solutions.lseg.com/MorningNewsCallEN-subscription-pageFor Morning News Call Ca...Reuters
16 hours ago
